Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced that Dane Leone, CFA, has joined Xencor as senior vice president, corporate strategy.
January 2, 2024
· 4 min read
